This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cruchaga, C. et al. Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease. Nature 505, 550–554 (2014)
Hooli, B. V. et al. PLD3 gene variants and Alzheimer's disease. Nature 520, http://dx.doi.org/10.1038/nature14040 (2015)
Kauwe, J. S. et al. Extreme cerebrospinal fluid amyloid beta levels identify family with late-onset Alzheimer's disease presenilin 1 mutation. Ann. Neurol. 61, 446–453 (2007)
Cruchaga, C. et al. Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families. PLoS ONE 7, e31039 (2012)
Rossor, M. N., Fox, N. C., Beck, J., Campbell, T. C. & Collinge, J. Incomplete penetrance of familial Alzheimer's disease in a pedigree with a novel presenilin-1 gene mutation. Lancet 347, 1560 (1996)
Llado, A. et al. A novel PSEN1 mutation (K239N) associated with Alzheimer's disease with wide range age of onset and slow progression. Eur. J. Neurol. 17, 994–996 (2010)
Bertram, L., Parrado, A. R. & Tanzi, R. E. TREM2 and neurodegenerative disease. N. Engl. J. Med. 369, 1565 (2013)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cruchaga, C., Goate, A. Cruchaga & Goate reply. Nature 520, E10 (2015). https://doi.org/10.1038/nature14041
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature14041
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.